Добавить новость
smi24.net
News in English
Июль
2023

Новости за 07.07.2023

RIL to fix record date for listing Reliance Strategic

Economictimes.indiatimes.com 

This March, RIL had said it plans to demerge its financial services undertaking into Reliance Strategic Investments Limited (RSIL) and rename and list it as Jio Financial Services Limited (JFSL).

Aster Healthcare's promoters in talks with private equity groups, look to sell India business

Economictimes.indiatimes.com 

Aster DM Healthcare’s founder Azad Moopen is in talks to sell a controlling stake in the India-listed hospital company to private equity firms including Blackstone and KKR. The company operates 32 hospitals in West Asia and India, as well as clinics, pharmacies, laboratories and patient experience centres. The discussions are preliminary and focus on a reverse merger with Care Hospitals, though both funds reportedly want a controlling stake or agreed path to control.



Christie says Trump kept classified docs because 'he wants to pretend he's still president'

TheHill.com 

Republican presidential candidate and former New Jersey Gov. Chris Christie (R) said Thursday that he believes former President Trump kept classified documents after leaving the White House because “he wants to pretend he’s still president.” “I think it was purely ego,” Christie told CNN’s Jake Tapper. “I think, Jake, he could not and still cannot...

'What Are They Hiding?': RFK Jr. Unhappy Biden Delayed Release of JFK Documents

RIA Novosti  

Despite a 1979 House review that concluded two or more shooters and co-conspirators were likely involved in the assassination, only Lee Harvey Oswald was accused of killing former US President John F. Kennedy. Oswald maintained his innocence until he was gunned down by Mafia-connected nightclub owner Jack Ruby before his trial.

PharmEasy value crash may not hit Velumani’s stake

Economictimes.indiatimes.com 

PharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per share that it secured in 2021. The huge fall in value has triggered questions about the fate of Velumani’s purchase of a 5% stake in the firm in 2021 when it was valued at $4 billion.

PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stake

Economictimes.indiatimes.com 

PharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per share that it secured in 2021. The huge fall in value has triggered questions about the fate of Velumani’s purchase of a 5% stake in the firm in 2021 when it was valued at $4 billion.





СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *